ATF6

Chr 1AR

activating transcription factor 6

Also known as: ACHM7, ATF6A, ATP6alpha

This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.701 OMIM phenotype
Clinical SummaryATF6
🧬
Gene-Disease Validity (ClinGen)
ATF6-related retinopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
49 unique Pathogenic / Likely Pathogenic· 248 VUS of 521 total submissions
📖
GeneReview available — ATF6
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.70LOEUF
pLI 0.000
Z-score 3.00
OE 0.47 (0.320.70)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.56Z-score
OE missense 0.92 (0.841.00)
323 obs / 352.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.47 (0.320.70)
00.351.4
Missense OE?0.92 (0.841.00)
00.61.4
Synonymous OE?1.05
01.21.6
LoF obs/exp: 17 / 36.6Missense obs/exp: 323 / 352.4Syn Z: -0.44
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveATF6-related achromatopsiaLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7034th %ile
GOF
0.2497th %ile
LOF
0.4430th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

521 submitted variants in ClinVar

Classification Summary

Pathogenic29
Likely Pathogenic20
VUS248
Likely Benign172
Benign24
Conflicting4
29
Pathogenic
20
Likely Pathogenic
248
VUS
172
Likely Benign
24
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
21
3
5
0
29
Likely Pathogenic
14
4
2
0
20
VUS
5
224
16
3
248
Likely Benign
0
6
73
93
172
Benign
0
7
8
9
24
Conflicting
4
Total40244104105497

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

14 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap ATF6 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ATF6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →